Skip to main content
. 2023 May 12;15(10):2284. doi: 10.3390/nu15102284

Table 1.

Treatment for CD.

Treatment Target Disease Concept References
Low-carbohydrate diet NICCD
CTLN2
Basal therapy [18,47,48]
MCT + lactose-restricted formula NICCD
CTLN2
Energy supply
Correction of metabolic disorder
[53,54,55,56,57,58]
Sodium pyruvate CTLN2 Energy supply
Correction of metabolic disorder
[59,60,61,62]
Ursodeoxycholic acid NICCD Hepatoprotection
Anti-cholestasis
[18,63,64,65]
Mannitol NICCD
CTLN2
Osmotic agent for treating brain edema due to hyperammonemia [51]
Liver transplantation * NICCD
CTLN2
Ultimate fundamental therapy [16,66,67,68,69]

* In Japan, liver transplantation is performed on recipients under 65 years old. CTLN-2, adult-onset type II citrullinemia; NICCD, neonatal intrahepatic cholestasis caused by citrin deficiency; MCT, medium-chain triglycerides.